Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects

YK Yong, HY Tan, A Saeidi, WF Wong… - Frontiers in …, 2019 - frontiersin.org
Tuberculosis (TB) treatment monitoring is paramount to clinical decision-making and the
host biomarkers appears to play a significant role. The currently available diagnostic …

Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics

C Napoli, G Benincasa, F Donatelli, G Ambrosio - American heart journal, 2020 - Elsevier
Heart failure (HF) management is challenging due to high clinical heterogeneity of this
disease which makes patients responding differently to evidence-based standard therapy …

Distinct epigenomic features in end-stage failing human hearts

M Movassagh, MK Choy, DA Knowles, L Cordeddu… - Circulation, 2011 - Am Heart Assoc
Background—The epigenome refers to marks on the genome, including DNA methylation
and histone modifications, that regulate the expression of underlying genes. A consistent …

Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I

M Kruse, E Schulze-Bahr, V Corfield… - The Journal of …, 2009 - Am Soc Clin Investig
Progressive familial heart block type I (PFHBI) is a progressive cardiac bundle branch
disease in the His-Purkinje system that exhibits autosomal-dominant inheritance. In 3 …

Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support

SJ Matkovich, DJ Van Booven, KA Youker… - Circulation, 2009 - Am Heart Assoc
Background—Much has been learned about transcriptional control of cardiac gene
expression in clinical and experimental congestive heart failure (CHF), but less is known …

Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure

M Movassagh, MK Choy, M Goddard, MR Bennett… - PloS one, 2010 - journals.plos.org
Epigenetic mechanisms such as microRNA and histone modification are crucially
responsible for dysregulated gene expression in heart failure. In contrast, the role of DNA …

[HTML][HTML] DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure

ME Pepin, S Drakos, CM Ha… - American Journal …, 2019 - journals.physiology.org
Heart failure (HF) is a leading cause of morbidity and mortality in the United States and
worldwide. As a multifactorial syndrome with unpredictable clinical outcomes, identifying the …

Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure

A Maciejak, M Kiliszek, M Michalak, D Tulacz… - Genome medicine, 2015 - Springer
Background Heart failure (HF) is the most common cause of morbidity and mortality in
developed countries. Here, we identify biologically relevant transcripts that are significantly …

Heart failure–associated changes in RNA splicing of sarcomere genes

SW Kong, YW Hu, JWK Ho, S Ikeda… - Circulation …, 2010 - Am Heart Assoc
Background—Alternative mRNA splicing is an important mechanism for regulation of gene
expression. Altered mRNA splicing occurs in association with several types of cancer, and a …

Update on myocarditis–what we know so far and where we may be heading

A Rroku, J Kottwitz, B Heidecker - European Heart Journal Acute …, 2021 - academic.oup.com
Myocarditis is defined as an inflammatory infiltration of the myocardium with associated
necrosis and/or degeneration, frequently resulting from different infectious or non-infectious …